TNF and rheumatoid arthritis: Interestingly, a high number of clinical evidence indicates that in OA joint tissues, serum, and synovial fluids, TNF-α is more elevated compared with healthy patients [75,76,77]; however, up to now, the use of anti–TNF-α therapeutics in humans is believed more efficacious in improving pain and joint mobility in RA than in the OA condition.